PERBANDINGAN HARGA SAHAM PERUSAHAAN FARMASI BUMN SEBELUM DAN SESUDAH PENGEMBANGAN VAKSIN VIRUS CORONA (COVID-19)

Authors

  • Morenly Marchel Welley Dosen Universitas Trinita Manado
  • Franky N. S Oroh Dosen Fakultas Pertanian Universitas Sam Ratulangi Manado
  • Mac Donald Walangitan Dosen Fakultas Ekonomi dan Bisnis Universitas Sam Ratulangi Manado

DOI:

https://doi.org/10.35794/jmbi.v7i3.31514

Abstract

ABSTRACT: The existence of an extraordinary event that occurred, namely the Covid-19 Pandemic, caused the global and national economies to experience obstacles. Not only does it have an impact on the economy, but this also has an impact on the capital market. The President's announcement regarding the development of the Covid-19 vaccine provides hope for the economy and capital market to revive. The state-owned pharmaceutical company appointed by the government has also benefited from vaccine development. The purpose of this study was to determine the difference in the share price of BUMN Pharmaceutical Companies before and after the development of the corona virus vaccine (Covid-19). The data analysis technique used in this study was the Paired sample t-test. The results showed that (1) the stock price of KAEF before the announcement of vaccine development and the stock price of KAEF after the announcement of vaccine development was a significant difference and (2) the stock price of INAF before the announcement of vaccine development and the stock price of INAF after the announcement of vaccine development had a significant difference.

References

Agus, S (2011). Manajemen Keuangan Teori dan Aplikasi. Yogyakarta: BPFE.

Brigham, F dan Houston, J. (2001). Dasar-Dasar Manajemen Keuangan. Edisi 8,. Buku 2. Jakarta: Salemba Empat.

Fahmi, I (2011) Analisa Laporan Keuangan, Bandung: Alfabeta.

Ghozali, I (2013). Aplikasi Analisis Multivariat dengan Program IBM SPSS. Edisi 7. Semarang: Penerbit Universitas Diponegoro.

Gorbalenya, A. E. (2020). Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group.

Jogiyanto (2017).Teori Portofolio Dan Analisis Investasi. Edisi. Kesepuluh. Yogyakarta:BPFE.

Junaedi dan Salistia (2020). Dampak Pandemi Covid-19 terhadap Pasar Modal di Indonesia Studi Kasus Indeks Saham Komposit (IHSG). Jurnal Ekonomi, Keuangan dan Bisnis Syariah

Meythi, dan S. Hartono (2012). Pengaruh Informasi Laba Dan Arus Kas Terhadap Harga Saham. Jurnal Ilmiah Akuntansi FE-UKM tahun ke-3, vol. 7.

Nasution, Erlina dan Muda, (2020). Dampak Pandemi COVID-19 terhadap Perekonomian Indonesia.. Jurnal Benefita Vol 5, No 2 (2020)

Pradana, N., dan Saputro. 2020. Pengaruh Sentimen Di Sosial Media Dengan Harga Saham Perusahaan. Jurnal Ilmiah Edutic/Vol.6, No.2, Mei 2020

Ratcliffe, R. (2020). "First coronavirus cases confirmed in Indonesia amid fears nation is ill-prepared for an outbreak". The Guardian.

Sugiyono (2014). Metode Penelitian Pendidikan Pendekatan Kuantitatif,. Kualitatif, dan R&D. Bandung: Alfabeta.

Triton, P. (2006). SPSS 13.0 Terapan; Riset Statistik Parametrik. Yogyakarta: C.V ANDI OFFSET.

Tulung, J. E., & Ramdani, D. (2015). The Influence of Top Management Team Characteristics on BPD Performance. International Research Journal of Business Studies, 8(3), 155-166.

Sekretariat Kabinet Republik Indonesia. 2020. Presiden Dukung Uji Klinis Vaksin Covid-19. https://setkab.go.id/presiden-dukung-uji-klinis-vaksin-covid-19/. Diakses tanggal 4 desember 2020.

Downloads

Published

2021-11-10

How to Cite

Welley, M. M., Oroh, F. N. S., & Walangitan, M. D. (2021). PERBANDINGAN HARGA SAHAM PERUSAHAAN FARMASI BUMN SEBELUM DAN SESUDAH PENGEMBANGAN VAKSIN VIRUS CORONA (COVID-19). JMBI UNSRAT (Jurnal Ilmiah Manajemen Bisnis Dan Inovasi Universitas Sam Ratulangi)., 7(3). https://doi.org/10.35794/jmbi.v7i3.31514